Jousma, E., Rizvi, T. A., Wu, J., Janhofer, D., Dombi, E., Dunn, R. S., . . . Ratner, N. (2015). Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of neurofibromatosis type 1. Pediatr Blood Cancer.
Παραπομπή Chicago StyleJousma, Edwin, et al. "Preclinical Assessments of the MEK Inhibitor PD-0325901 in a Mouse Model of Neurofibromatosis Type 1." Pediatr Blood Cancer 2015.
Παραπομπή MLAJousma, Edwin, et al. "Preclinical Assessments of the MEK Inhibitor PD-0325901 in a Mouse Model of Neurofibromatosis Type 1." Pediatr Blood Cancer 2015.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.